Show simple item record

dc.contributor.authorJarrell, Bruce E.
dc.contributor.authorSuntha, Mohan
dc.date.accessioned2021-01-04T19:48:30Z
dc.date.available2021-01-04T19:48:30Z
dc.date.issued2020-12-13
dc.identifier.urihttp://hdl.handle.net/10713/14262
dc.descriptionLetter from UMB President Bruce Jarrell, MD, and UMMS CEO and President Mohan Suntha, MD, MBA, announcing the FDA's emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine and approval by the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) for use in the United States. With the 2 approvals UMB and UMMS will proceed with a unified vaccination effort.en_US
dc.language.isoen_USen_US
dc.subjectCoronavirus Disease 2019 (COVID-19)en_US
dc.subject.lcshCOVID-19 (Disease)en_US
dc.subject.lcshUniversity of Maryland, Baltimoreen_US
dc.subject.lcshUniversity of Maryland Medical Systemen_US
dc.subject.meshCOVID-19en_US
dc.subject.meshCOVID-19 Vaccinesen_US
dc.titleA Message from Drs. Jarrell and Suntha: COVID-19 Vaccine Approvalen_US
dc.typeLetter/Memoen_US
refterms.dateFOA2021-01-04T19:48:32Z


Files in this item

Thumbnail
Name:
Jarrell_Suntha_ReCOVID-19Vacci ...
Size:
121.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record